ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Internal Medicine

Top Internal Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SARAH GOODMAN D.O.

Internal Medicine

1,059

$82.9K

142
71 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$78
Average prescription price

Avg: $61

CHRISTEN PRIBLE M.D.

Internal Medicine

1,062

$60.9K

83
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

34%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $61

CARRIE SUN MD

Internal Medicine

1,077

$41.1K

190
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$38
Average prescription price

Avg: $61

ROBERT LOVE MD

Internal Medicine

1,093

$76.7K

82
66 are 65+

15%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $61

ALVARO LAPITZ

Internal Medicine

1,102

$103K

214
89 are 65+

43%
patients receiving schedule two controlled substances

Avg: 6%

43%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$94
Average prescription price

Avg: $61

MALAK HERMINA

Internal Medicine

1,119

$77.8K

56
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $61

ADAM SPAETTI MD

Internal Medicine

1,129

$86.5K

120
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$77
Average prescription price

Avg: $61

CHRISTINE DAVIS M.D..

Internal Medicine

1,146

$62.4K

125
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $61

JACQUELINE TRUEBLOOD M.D.

Internal Medicine

1,156

$57.8K

531
382 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

6%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $61

RONALD SCHEERINGA MD

Internal Medicine

1,167

$90.7K

49
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$78
Average prescription price

Avg: $61

ROMANA MALIK

Internal Medicine

1,202

$65.7K

59
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $61

ADRIENNE EINHORN MD

Internal Medicine

1,209

$88.4K

91
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$73
Average prescription price

Avg: $61

PATRICK LOMASNEY MD

Internal Medicine

1,238

$68.3K

109
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $61

WILLIAM WASHINGTON M.D.

Internal Medicine

1,242

$39.2K

80
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$32
Average prescription price

Avg: $61

STANISLAWA KOCZOROWSKA MD

Internal Medicine

1,242

$75.3K

58
26 are 65+

43%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

ALARMELU SAMBANDAM D.O.

Internal Medicine

1,262

$46.2K

108
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$37
Average prescription price

Avg: $61

STEPHEN KNAUS MD

Internal Medicine

1,271

$104K

75
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$82
Average prescription price

Avg: $61

JITENDRA AMIN MD

Internal Medicine

1,278

$75.9K

97
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

NANCY NOEL MD

Internal Medicine

1,278

$83.5K

102
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $61

GREGORY WISEMAN M.D.

Internal Medicine

1,308

$85.3K

112
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $61

LINA KHAMIS MD

Internal Medicine

1,316

$84.5K

94
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

DEBRA LITZELMAN

Internal Medicine

1,322

$76.7K

53
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $61

ANEMARIA LUTAS MD

Internal Medicine

1,350

$82.4K

88
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

26%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

LISA ALTUGLU M.D.

Internal Medicine

1,353

$71K

151
106 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $61

CHARLES KELLEY MD

Internal Medicine

1,356

$83K

112
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank